← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #811 OF 1,000 MOST-CITED

Management ensuring quality policy is understood

FDA cited this observation 19 times across 19 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Devices19
BY FISCAL YEAR
FY20254
FY20245
FY20234
FY20221
FY20201
FY20191
FY20173

How FDA worded it — real examples

Management with executive responsibility has not ensured that the quality policy is understood, implemented and maintained at all levels of the organization.

Magnatone Hearing Aid Corp · Casselberry, Florida · Devices · 2025-07-14

Management with executive responsibility has not ensured that the quality policy is understood, implemented and maintained at all levels of the organization.

Pointcore Supply Chain Service LLC · Peoria, Illinois · Devices · 2025-06-26

Management with executive responsibility has not ensured that the quality policy is understood, implemented and maintained at all levels of the organization.

Phoenix Instruments Inc. · Lisle, Illinois · Devices · 2025-05-30

Management with executive responsibility has not ensured that the quality policy is understood, implemented and maintained at all levels of the organization.

Advanced Instrumentations, Inc. · Miami, Florida · Devices · 2025-04-17

Management with executive responsibility has not ensured that the quality policy is understood, implemented and maintained at all levels of the organization.

Little Rapids Corporation · Green Bay, Wisconsin · Devices · 2024-08-23

Management with executive responsibility has not ensured that the quality policy is understood, implemented and maintained at all levels of the organization.

Kawasumi Laboratories (Thailand) Co. Ltd. · Chok Chai · Devices · 2024-07-25

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Medical devices

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →